SBC Medical Group Expands into Thailand Through Strategic Partnership with BLEZ ASIA

SBC Medical Group Holdings Inc., Japan's leading aesthetic medical clinic operator, has entered an e-consulting agreement with BLEZ ASIA Co., Ltd. to expand into Thailand, focusing on establishing a dermatological clinic in Bangkok's Asok district by year-end. This marks SBC's second international expansion following its 2024 entry into Singapore, representing a key component of its broader Asia expansion strategy. The Thai market presents significant opportunity, with demand for aesthetic medicine projected to reach nearly $1.2 billion by 2033, growing at a compound annual growth rate of 13.5%.

Thailand's fragmented market of small-scale operators providing inconsistent service, combined with a Japanese expatriate population of approximately 60,000 seeking Japanese-quality treatments, creates ideal conditions for SBC's expansion. BLEZ ASIA operates more than twenty pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriates and local patients, making it a strategic partner for SBC's entry. Under the agreement, SBC will provide management support to the new clinic, advising on clinical protocols aligned with SBC's quality standards and assisting in selecting medical devices and treatment methods optimized for local skin characteristics and environmental conditions.

The clinic will primarily focus on dermatological treatments such as pigmentation and spot removal, addressing customer demand for high-quality, affordable aesthetic treatments that offer subtle, natural-looking enhancements with minimal downtime. Yoshiyuki Aikawa, CEO of SBC, emphasized the strategic importance of the move, stating that Japanese aesthetic medicine is globally competitive for its precision and high safety standards. Partnering with a trusted local leader like BLEZ in the fast-growing Thai market represents a significant step forward in SBC's Asia strategy, as detailed in their corporate announcements at https://www.sbcmedicalgroup.com/news.

The company aims to create a model where Japan's advanced medical services can take root locally and deliver new value, beginning with the Japanese expatriate community before expanding to serve the broader Thai market. This expansion comes as SBC reports strong performance in its domestic market, with annual patient visits growing 15% year-over-year in the third quarter and a return customer rate of 72%. The company recently overhauled its pricing structure to attract and retain customers while maintaining competitive positioning in Japan, accelerating regional growth following its Singapore launch through partnership with Aesthetic Healthcare Holdings.

Naoki Iida, CEO of BLEZ ASIA, noted that the Thai aesthetic medicine market continues to grow rapidly with increasing focus on quality and safety, making the partnership with SBC an invaluable opportunity to establish Japanese-standard, high-quality medical services in Thailand. Both companies aim to build a brand trusted and loved by the community for years to come, combining SBC's medical expertise with BLEZ ASIA's local market knowledge and established reputation, as highlighted in their joint statement at https://www.blezasia.co.th/partnerships. This expansion represents SBC's continued commitment to providing consistently high-level medical services while establishing new value in international aesthetic medicine markets.